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       This project aimed to obtain a set of fluorescent nucleoside analogues 
that closely resemble cytosine with extending the aromatic surface 
(extended conjugation) for enhance the photophysical properties.  In 
addition to synthesize new fluorescent nucleoside analogues and evaluate 
their photophysical properties, this project aimed to understand the effects 
of donor substituent on the tC photophysical properties.      
       The main goal of these studies is to develop highly fluorescent 
nucleotide analogues. We first were looking to synthesize tCC fluorescent 
nucleotide with the pyrimido[4,5-b]quinolone. In this part, 2-chloro-3-
formylquinoline was easily prepared, yet the cyclization of 2-chloro-3-
formylquinoline with urea or guanidine HCl was the most challenging that 
faced us. However, we have synthesized 2-amino [4,5-b]quinoline-one ring 
tCC  under super dry reaction conditions in <10% yield.  
      The second goal was synthesizing new modified fluorescent nucleoside 
derivatives of tricyclic cytidine, which structurally mimics natural cytidine, 
and evaluates the photophysical properties of the new fluorescent tC 
nucleoside to understand the affects of the donor substituent, OCH3, group 
on tC. In this part, we have reported new tC nucleoside derivatives with 
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electrons donor substituent OCH3 group at carbon 7, tC7OMe, and the other 
at carbon 8, tC8OMe. These different substitution positions offer important 
distinctions between the design of the tC, tC8OMe, and tC7OMe. The 
unsubstituted tC nucleoside was easy to synthesize. In contrast, the 
synthetic strategy of the tC7OMe nucleoside that has electron donor 
substituent group OCH3 located at carbon 7 and para to amino group is 
synthetically less challenging and higher yielding than synthesis of tC8OMe 
which has OCH3 group substituent meta to amine group. Moreover, the 
photophysical properties of the fluorescent nucleoside derivatives of tC 
have been evaluated. Fluorescence studies of modified tC nucleosides 
demonstrated distinguish fluorescence emission and absorption 
wavelengths for tC7OMe, and tC8OMe, which displayed higher quantum yields 
and brightness compared to unmodified tC, dependent on mismatch 
position of the electron donor group (7 or 8) on the tC.  This can be 
explained by the fact that the donor group OCH3 which allow for extended 
conjugation of unshared pairs of electrons lead to increases the freedom of 
the -electrons and likely to raise the fluorescence.   Also, our fluorescence 
study established that there are effects of the different positions of 
substituent donor group. The fluorescence emission wavelength of tC8OMe, 
where the OCH3 is meta to amino group, is red sifted longer than the 
fluorescence emission wavelength of tC7OMe, where the OCH3 is para to 
amino group; however, tC7OMe exhibited higher quantum yield and 
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1.1  Deoxyribonucleotides (DNA) 
 
       In 1953 the three-dimensional structure of the DNA double helix, which 
is two polynucleotide chains twisted around each other bonded via 
hydrogen bonds in the form of a double helix (Figure 1.1), was discovered 
by Watson and Crick.1 Since that time, DNA, which is considered a key 
component of life, became the focus of many researchers.  DNA (genetic 
material) 2 is a molecule that is responsible for storage, duplication, and 
investigation of the genetic information in bodies of living organisms; 














1.1.1 Major Structures of DNA: 
 
        In the double helix DNA the residues (nucleotides) are built up of four 
bases: adenine (A) , thymine (T), cytosine (C) and guanine (G) that are 
connected via specific binding between the nitrogenous nucleobases  
knows as  Watson-Crick hydrogen bonding, adenine (A) always pairs with 
thymine (T) / (uracil (U) in case of RNA) and visa versa, while guanine (G) 
always pairs with cytosine (C) and visa versa 3 (Figure 1.2).  
 







1.1.2 Nucleosides and Nucleotides 
 
     Nucleotides are monomeric biomolecular units of nucleic acids (DNA 
and RNA) that are created from nucleosides. Nucleotides consist of three 
components covalently bonded together: 1 (Figure1.3) 
I. Nitrogenous Bases  (Heterocyclic bases) 
The nitrogenous bases of DNA are divided into two classes 
Purines(bicyclic)  
             1.  Guanine.    2- amino-6-oxypurine (figure1.4 a) 
           2.   Adenine     6-aminopurine (figure1.4 b) 
 Pyrimidines (monocyclic)  
   1.  Cytosine   2-oxy-4-amino pyrimidine (figure1.4c) 
2.  Thymine   2,4-oxy 5-methyl pyrimidine (DNA) (figure1.4d) 
3.  Uracil       2,4-oxypyrimidine  (RNA) (figure 1.4e) 
II.   A Pentose (5-carbon sugar) – ribose or 2′-deoxyribose.. 
       These nitrogenous bases are connected to the five membered ring 
sugar, a furanose,  via a β-glycosidic bond (figure1.3). 
III.   A Phosphate Group  
       Nucleotides have one, two or three phosphate group(s), while the 
nucleosides have a hydrogen atom instead of the phosphate group(s).1   
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Phosphate groups are bridge linkages that link nucleotides in a phospho-
diester backbone between the 3' carbon of one deoxyribose molecule and 
the 5' carbon of another.  
 


























1.2  Fluorescence: 
1.2.1  The Fluorescence Process (Fluorescence 
Fundamentals) 
 
         The process of fluorescence can be illustrated in a simplified diagram 
known as the diagram of Electronic Transitions or Jablonski diagram 
(Scheme1.1).  Jablonski diagram shows that fluorescence is a result of two 
stages. The first stage is excitation which occurs when an electron is 
excited from the ground state (S0) to a singlet lowest excited state (S1) by 
absorption of light (photons). The second stage is relaxation from the 
excited state (S1), via different processes involved:  Fluorescence occurs 
when an electron relaxes from the lowest level of an excited singlet state 
(S1) to the singlet ground state (S0). Intersystem crossing occurs when a 
photon relaxes from the lowest level of an excited singlet state (S1) to the 
triplet excited state (T1). Phosphorescence occurs when a photon is 





   
 
1.2.2  Fluorescence Spectroscopy 
         Fluorescence spectroscopy techniques are methods of analysis that 
depend on the fundamental nature of the transitions involved where the 
electrons of the analyte are excited to higher electronic states by irradiation 
(absorbed photons) at a certain wavelength and emit radiation of a different 
wavelength when relaxing back to the ground state.6   
           Fluorescence spectroscopy techniques have features such as 
providing high detection sensitivity, unparalleled time resolution,  and can 
easily be performed under several solution conditions.7 These 
characteristics make them classified  as indispensable tools in the study of 
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structure and dynamics of biological molecules 7 and study photophysical 
properties of fluorescent molecules,  fluorophore (fluorochrome),  such as 
absorption wavelength λabs, emission wavelength λem, quantum efficiency 
φF, and excited state lifetime τ.  Each  fluorophore has a characteristic light 
excitation and emission spectrum where the emission energy is at  lower 
energy and longer wavelength than the excitation energy.5  
1.2.3 Fluorescence Resonance Energy Transfer (FRET) :                           
      Förster resonance energy transfer, more commonly known as 
Fluorescence resonance energy transfer (FRET), 8 is one of the most 
important fluorescence techniques that are utilized widely in biotechnology 
measurements, such as single-molecule imaging techniques, probes for 
structural and functional analyses, for investigating structure and dynamics 
of biopolymers, and molecular beacons. 
       FRET is not sensitive to the environment, as a result, the information of 
fluorescence measurements relate exclusively to the changes in the 
conformation of the biopolymer under study.9   
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        FRET mechanism (Figure 1.5) , involves two fluorophores, a donor and 
an acceptor. Excitation of the donor by absorption of light at one wavelength 
results in transfer of energy directly to the acceptor which emits a radiation 
at a longer wavelength (Scheme 1.2). This process depends on certain 
criteria and requirements that must be met for FRET to occur. The physical 
orientation of the transition dipoles of donor and acceptor fluorophores must 
be approximately parallel to each other, and the distance between a donor 
and acceptor molecule. The effective distance between the donor and 
acceptor is in the range of 10–100 Å. In addition, the fluorescence emission 
spectrum of the donor and the absorption or excitation spectrum of the 


























Contact quenching No Contact quenching
Contact quenching No Contact quenching  
    
Scheme 1.5: Overview of energy transfer and fluorescence FRET  
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1.3   Fluorescent Nucleotide Analogues  
 
        The normal nucleic acid bases provide short decay times (lifetime); as 
a result, the natural fluorescence of DNA or RNA is very weak,27 also the 
signals are effectively averaged over all the bases in the DNA chain; 
consequently, the natural nucleobases do not provide much structural 
information. The replacement of a normal base with a modified base can 
enhance the emissive properties of the nucleoside.7    
       Many scientists are interested in synthesizing novel fluorescent 
nucleotide base analogues because of  the importance of their utility in 
many analytical applications such as detection, quantification of nucleic 
acids and study of their structure, dynamics, hybridization, and interaction 
with other molecules.11  Therefore, fluorescent nucleic acid base analogues 
are very important probes in several fields such as organic chemistry, 
physics, biochemistry, and biology.11 Replacing the DNA bases by 
fluorescent hydrocarbons and heterocyclic nucleic acid base analogues 






1.3.1    Classification of Fluorescent nucleobases 
  I.  According to Structure 
       Fluorescent nucleobases that resembles the natural DNA bases have 
several features that make them an important aim for researchers. 12 That 
nucleobases which mimic the natural DNA nucleosides are classified into 
two groups according to their structure:  
(a) Fluorescent purine analogues, 13 such as 2-aminopurine 
(Figure 1.5a), Etheno-A (Figure 1.5b) 3-methylisoxanthopterin 
(Figure 1.5c), and 6-methylisoxanthopterine (Figure 1.5d) 
(b) Fluorescent pyrimidine analogues, 13 such as furyl-U (Figure 
1.6a), pyrrolo-C (Figure 1.6b), 5- benzopyridopyrimidine(Figure 
1.6c), and 3,5-diaza-4-oxophenothiazine (tC) (Figure1.6d), bicyclic 
4-N-carbamoyldeoxycytidine derivative, pyrrolopyrimidopyrimidine, 





































Figure1.5: Fluorescent purine analogs (a) 2-Aminopurine (2-AP), (b) Etheno-A,(c)









II.   According to their Environmental Sensitivity 
II.I   Environmentally Sensitive Fluorescent Base Analogue s 
       Whereas fluorescent nucleobases have great utility as reporters for 
enzyme function and as probes of nucleic acid sequence and structure, 
some of the fluorescent nucleobases are environmentally sensitive and 
influenced by neighboring bases.11  Although several environmentally 
sensitive nucleobases have distinctive  fluorescent properties and are used 
as  powerful tools for investigating the perturbations, nucleic acid structure, 
dynamics, and recognition, they have some limitations.12,14,15 For instance, 
the environment-sensitive fluorescent base analogues could be affected by 
neighboring bases and lose their fluorescence, being quenched, during 
duplex formation probe. In addition to quenching by neighboring bases they 
usually produce low quantum yields.11  These probes can be categorized 
as:   isomorphic base analogues, e.g. 2-aminopurine (2AP), pteridines e.g 
3-methylisoxanthopterin (3-MI) and 6-methylisoxanthopterin (figure.1.5), 
and expanded nucleobases, e.g. pyrrolo-dc (figure.1.7)  and some 
fluorescent cytosine analogues  developed by Sekine et al (Figure 1.8) and 
BDF nucleoside analogues developed by Saito et al. (Figure 1.9) analogues  
15 
 
(a) 5-methylpyrimidin-2-one, (b) 7-deazapurines, (c) 5-alkynyluridines, (d ) 
















II.II Environmentally Insensitive Fluorescent Base Analogues 
          Environment-insensitive fluorescent base analogues are the most 
important in experiments that depend on the emission for detection and 
where FRET and anisotropy measurements are used 17 because they have 
shown a high fluorescent quantum yield when incorporated into 
oligonucleotides. Almost all fluorescent nucleobase analogs are quenched 
in duplex nucleic acids, whereas it has been demonstrated that the tricyclic 
cytosine analogue tC family, phenothiazine, 1,3-diaza-2-oxophenothiazine, 
18 
 
and tCO, phenoxazine,1,3-diaza-2-oxophenoxazine (Figure 1.11 a,b) are 
fluorescent have shown a high fluorescent quantum yield when incorporated 
into oligonucleotides. 18 Also, the non-fluorescent tCnitro  (Figure 1.11 c) is 
part of tC family consider  as an important molecule because it is the first 
nucleobase FRET-pair, yielding accurate distance and orientation 
information in DNA .19,25,26 
                      
 
1.4  Aims of the Project: 
       The goals of this project are: to synthesize novel fluorescent nucleoside 
analogues that can participate in Watson-Crick hydrogen bonding (Figure 
1.12) and afford high brightness, quantum yields (ΦF), high molar extinction 
coefficient (ε), and distinguish absorptions. Also, to synthesize different 
derivatives of tC for understanding the affects of donor ring substitution at 








































Figure 1.12: Fluorescent nucleoside analogues
H
 
        Most fluorescent probes that exist today have limitations; for instance, 
some probes are very sensitive to the micro-environment when          
incorporated into an oligonucleotide and will be quenched, as it is 
mentionedpreviously.  Also, some fluorescent nucleotides that currently 
exist have a fluorophore covalently attached via a flexible linker at C-5 eg. 
Cy5-dC, Cy3-dC (Figure 1.13), 24 this flexibility of the linker could displace 
the fluorophore from the target position.  Moreover, the flexibility impairs the 
use of the dye anisotropy, which prevented the direct observation of 
conformational rigidity imposed on the nucleobase. The fluorophore 
tethered bases have a different size and hydrophobicity compared to the 
natural base, thereby precluding their normal interaction with the DNA and 
RNA in the cell.  Although Cy5 exhibit high red shift excitation at 635 nm and 
20 
 
emission at 670–720 nm 22 with high quantum yield when linked to DNA, 
they are sensitive to their environment and it is worth mentioning that  Cy3 
fluorescence is sensitive to not only  the closest base, but also to several 




Figure 1.13:  Fluorescent base analogues consist of conventional dyes tethered covalently 




       The tricyclic fluorescent base analogues tC and tCO (figure 1.11 a,b)  
have been reported with unique fluorescence properties; for example, the tC 
derivatives are  relatively insensitive to neighboring bases because their 
fluorescent intensity is virtually not affected by neighbors when it is 
incorporated into single and double-stranded oligonucleotides.12  In addition, 
they usually generate brightness and quantum yield tCO is around 0.14 – 
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0.41, tC 0.219 insensitive when incorporated into single and double-stranded 
oligonucleotides.12 Furthermore, these analogs are able to enhance the 
stability of oligodeoxynucleotides /RNA duplexes; 18  thus, tC can be useful 
for investigating intrinsic characteristics of nucleic acid as well as 
interactions between nucleic acids and other molecules. 16 Lin, K. et al. 
1995, have found that both the phenothiazine and phenoxazine (Figure1.11) 
result in greatest duplex stability when tricyclic heterocycles are positioned 
together, showing π- π overlap between adjacent aromatic faces which is 
not possible in analogs of less than three rings. 18   However, all base-pairing 
partners of tC that have been reported such as tC and tCO (Figure 1.11) 
have similar absorption and emission wavelengths, so that it is difficult to 
distinguish between them. Therefore, we were looking forward to 
synthesizing novel modified tC fluorescent nucleoside analogs have higher 
brightness, less environmental sensitivity, and have distinguishable 
fluorescence emission and absorption wavelengths. 
Hypothesis  
      We have assumed that extended the aromatic surface (extend the π 
system) of the natural base, such as the pyrimidine, results in useful 
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fluorescent properties. Accordingly, we were looking for synthesizing 
pyrimido[4,5-b]quinoline-2(1H)-one ring system tCC derivatives. 
      Furthermore, according to the fact that photophysical characteristics 
(e.g., red shifted absorption and high emission quantum efficiencies) 
depend on the structure of the molecule. 20 We expected that the functional 
groups which allow for extended conjugation of unshared pairs of electrons, 
such as alcohol, amine, amide, and ether, would raise the fluorescence 
intensity and the quantum yield. Moreover, we have hypothesized that the 
position of the substituent would affect the fluorescence intensity, the 
absorption, and emission wavelength, and the quantum yield.21 
  In order to understand the effects of the donor substituent group OCH3, 
we reported two new nucleosides, tC8OMe and tC7OMe, that arose from the 
design of the tC nucleosides as will discuss in Chapter 3. Although the 
tC8OMe and tC7OMe nucleosides arose from the skeleton of the tC 
nucleosides, the modification function groups, OCH3, at different positions 
7C and 8C would bring different photophysical properties according to the 
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Nucleobase analogues with the pyrimido[4,5-b]quinol ine-




        In this part of our procedure, the main goal was  to develop highly 
fluorescent nucleotide analogues.  We were looking to synthesize the tCC 
fluorescent nucleotide with the pyrimido[4,5-b]quinoline-2(1H)-one ring 
system (Figure 2.1). 
        Pyrimidoquinolines derivatives are an important class of heterocyclic 
molecules because of their partial similarity to the natural acid bases that  
enhances the probability of being able to act as a nucleobase (Figure 2.1).  
In general, quinoline molecules have been utilizing extensively in medicinal 
chemistry and biomedical field.1,2,6 For instance, they are active  as 
antiarrhythmic, antimalarials, antimicrobial, anti-inflammatory, anticancer,1  
and analgesic agents.3   As a result of the wide ranging applications of 
quinoline derivatives, the synthesis of quinoline derivatives became an 
attractive goal for many scientists. 
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       The intermediate compound 2-chloro-3-formylquinoline was easily 
prepared, yet the cyclization of 2-chloro-3-formylquinoline with urea or 
guanidine HCl was the most challenging aspect of the synthesis. However, 
we have successfully synthesized 2-amino [4,5-b]quinoline-one ring tCC  
under super dry reaction conditions with <10 yield. 
       
                            
   The tricyclic cytosine nucleobases allow for the formation of two 
tautomeric configurations. 4 This tautomerization provides two possible 
configurations which are acceptor-acceptor-acceptor (AAA) and donor- 




            
2.2 Synthesis of tC C nucleobase analogues 
      The reactions sequences were begun with acetanilides, which were 
easily converted to 2-chloro-3-formylquinolines by treatment with the 
Vilsmeier reagent.1 Unfortunately, condensation of 2-chloro-3-
formylquinoline with urea in a heated solution of acetic acid was not 
successful in producing the fluorescent tricyclic tCC analogues pyrimido[4,5-
b]quinoline-2(1H)-one.  Instead the compound 2-chloro-3-formylquinoline 
was hydrolyzed because of water present in the reaction mixture that acts 
as a nucleophile and causes substitution at the chlorine atom preventing 





2.2.1   Synthesis of tC COMe  nucleobase    
                           
 
        In order to synthesize 8-methoxy-pyrimido[4,5-b]quinoline-2(1H)-one 
tCC (Figure 2.2.1), the first step was to prepare 3'-methoxy acetanilide (2) 
which was obtained by reacting acetic anhydride with m- anisidine  in the 
presence of pyridine at room temperature.  Subsequent synthesis of 2-
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chloro-7-methoxy-quinoline-3-carbaldehyde (3) was completed by treatment 
of 3’-methoxy acetanilide (2) with dimethylformamide (DMF) and phosphoryl 
chloride (Vilsmeier's reagent, VR ).7  Unfortunately, cyclization of (3) with 
urea and acetic acid in order to generate the target product 8-methoxy-
pyrimido[4,5-b]quinoline-2(1H)-one tCC (4) did not occur probably because 
of water present in the sample that hydrolyzes the intermediate compound 
2-chloro-3-formylquinoline preventing the coupling with urea. The scheme 


































2.2.2 Synthesis of tC cex nucleobase 
 
 
    
 
          In order to prepare methoxy-tetracyclic cytosine tccex
 
(9) (Figure 
2.2.2), the reaction started by preparing 2-naphthylacetamide (6) which was 
obtained by reacting acetic anhydride with 2-naphthylamine (5) in the 
presence of pyridine at room temperature.  The attempt to prepare 2-chloro-
3-formylnaphthylquinoline (8) by treatment of 2-naphthylacetamide (6) with 
dimethylformamide (DMF) and phosphoryl chloride (Vilsmeier's reagent, 
VR) produced compound (7) instead of (8) because of the preferred 
reactivity of electrophiles at position 8 over the position 2 in quinolines.  
Unfortunately, condensation of (7) with urea in a heated solution of acetic 
acid was not successful in producing the fluorescent tricyclic analogues 
methoxy-tetracyclic cytosine tccex
 























































2.2.3 Synthesis of tC COH nucleobase 
 
                         
 
 
       In order to prepare the molecule tCCOH (Figure 2.2.3) the reaction was 
started by preparing acetamide (10) with a protected substituent group. This 
was obtained by treatment of 3-acetamidophenol (9) with NaH and methyl 
chloromethyl ether (MOMCl) commonly used as a protecting group for 
alcohols. Treatment of the acetamide (10) with Vilsmeier's reagent was not 
successful in producing the produce (11).   






2.2.4   Synthesis of tC C nucleobase 
 
 
                        
 
 
 In order to prepare pyrimido[4,5-b]quinoline-2(1H)-one ring tCC, (16) 
(Figure 2.2.4) the reaction was started by preparing 2-chloro-3-
formylquinoline (14) from the treatment of  acetanilide (13) with 
dimethylformamide (DMF) and phosphoryl chloride (Vilsmeier's reagent, 
VR).  We were able to cyclize the 2-chloro-3-formylquinoline (14) with 
guanidine HCl in the presence of sodium hydride base to generate the 






















2.3 Experimental   
Synthesis of nucleobase analogues with the pyrimido [4,5-
b]quinoline-2(1H)-one ring system tC C 
 
General   
 
 
 Solvents and reagents were obtained from commercial suppliers and 
used without further purification.  All moisture and oxygen sensitive 
reactions were carried out under nitrogen.  Air and moisture sensitive 
solvents and solutions of reactions were transferred using syringes. 
Reactions were monitored by thin layer chromatography (TLC). NMR 
spectra were recorded on Bruker Avance 500MHz spectrometer. Unless 








                     
 
3'-methoxy acetanilide (2).    
 
        m-anisidien (1) (44.5mmmol, 5 mL) was added to  pyridine (50 mL) in  
acetic anhydride (17 mL). The mixture was stirred at room temperature for 3 
h.  The reaction was quenched by addition of methanol. The crude product 
was dissolved in ethyl acetate and washed with 1M HCl (2 x 100 mL) then 
with NaHCO3 (2 x 100 mL) then brine (1x 100 mL). The organic layer was 
dried over anhydrous Na2SO4. The solvent was evaporated using a rotary 
evaporator. Purification via flash column chromatography on silica gel (6% 
CH3OH in CH2Cl2) afforded the desired product (2) that was identified via 1H 
NMR (6.54 g, 89% yield) (scheme 2.3.1). 1H NMR (500 MHz, Chloroform-
d, 294 K):  δ 7.64 (1 H, s), 7.27 (1 H, s), 7.19 (1 H, t, J 8.1), 6.98 (1 H, dd, J 
8.0, 1.9), 6.65 (1 H, dd, J 8.2, 2.5), 3.77 (3 H, s), 2.15 (3 H, s). 
 




 2-chloro-7-methoxy-quinoline-3-carbaldehyde (3).  
       Dry DMF (5.75 mL) and POCl3 (7.9 mL) were stirred at 0° C under 
nitrogen.  3'-methoxy-acetanilide (2) (30.26 mmol, 5 g) was added to the 
solution.  The reaction mixture was stirred at room temperature 10 min then 
heated at 75° C for 4 h.  The progress of the reaction was monitored by TLC. 
The liquid product was added to ice water generating yellow precipitate that 
was collected by filtration and washed with water yielding the desired 
product (3) (3.55 g, 53% yield) (scheme 2.3.2).   1H NMR (500 MHz, DMSO-
d6, 294 K):  δ 12.09 (1 H, s), 10.18 (1 H, s), 8.44 (1 H, s), 6.89 (1 H, d, J 8.8, 




                      
      
8-methoxy-pyrimido[4,5-b]quinoline-2(1H)-one tC C base (4).    
        2-chloro-7-methoxy-3-formylquinoline (3) (4.51 mmol, 1 g) was added 
to urea (47.95 mmol, 2.88 g)  in  acetic acid (20 mL). The mixture was 
heated at 80° C for 2 h. The liquid product was added to ice water and then 
sodium bicarbonate was added slowly producing orange precipitate that 
was collected by filtration and washed with water. Orange fluorescent 
powder was the obtained product. Unfortunately, the NMR measurement 
shows only the hydrolyzed compound probably because of water present in 




                            
                  
2-naphthylacetamide (6).   
        2-naphthylamine (5) (6.26mmol, 0.9 g) was stirred in acetic anhydride 
(2.3 mL) in the presence of pyridine (7.1 mL) at room temperature for 3 h. 
Methanol was added to quench the reaction. The crude product was 
dissolved in ethyl acetate and washed with 1M HCl (2 x 100 mL) then with 
NaHCO3 (2 x 100 mL) then brine (saturated NaCl 1x 100 mL) .The organic 
layer was dried over anhydrous Na2SO4, and the solvent was removed by 
evaporation. Purification via flash column chromatography on silica gel (6% 
CH3OH in CH2Cl2) afforded the desired product (6) (0.8296 g, 71.5% yield) 
(scheme 2.3.4).  1H NMR (500 MHz, Chloroform-d, 294 K):  δ 8.19 (1 H, s), 
7.77 (4 H, dd, J 7.3, 4.6), 7.45 (2 H, ddd, J 8.1, 4.2, 1.9), 7.39 (1 H, s), 2.23 























    
2-chloro-3-formylnaphthylquinoline (8).   
       Dry DMF (0.72 mL) and POCl3 (2.5 mL) were stirred at 0
° C under 
nitrogen. 2-naphthylacetamide (6) (4.427 mmol, 0.829 g) was added to the 
solution and the reaction mixture was stirred at room temperature for 10 
min.  Then the mixture was heated at 75° C overnight.  Then the liquid 
product was added to ice water generating precipitate.  The orange 
precipitate was collected by filtration and washed with water. Purification via 
flash column chromatography on silica gel (15% ethyl acetate in hexanes 
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then 30% ethyl acetate in CH2Cl2) resulted in the desired product (7) which 
was collected and concentrated by evaporating the solvent with a rotary 
evaporator (0.879 g, 72% yield) (scheme 2.3.5). 1H NMR (500 MHz, 
Chloroform-d, 294 K):  δ 10.64 (1 H, s), 9.51 (1 H, s), 8.71 (1 H, d, J 8.3), 
8.17 (1 H, d, J 9.1), 8.00 (1 H, d), 7.96 (1 H, d, J 9.2), 7.81 (1 H, t, J 8.0), 
7.75 (1 H, t, J 7.5). 
                       
               
Methoxy-tetracyclic cytosine tc Cex
 
(9).  
      2-chloro-3-formyl naphthyl quinoline (7) (0.413mmol, 0.1g) was added to 
urea (0.413 mmol, 0.028) in (2 mL) acetic acid.  The mixture was heated at 
80° C 2 h.  The liquid product was added to ice water and then sodium 
bicarbonate was added producing an orange precipitate that was collected 
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by filtration and washed with water. Orange fluorescent powder was 
obtained (Scheme 2.3.6). Purification was performed via flash column 
chromatography on silica gel (4% methanol in CH2Cl2), but 
1H NMR (500 
MHz, CDCl3) measurements showed the target product tC
Cex was not 
produced.  
                   
 
acetamide with protected group (10).  
       3-acetamidophenol (9) (6.6 mmol,1g) was added to  NaH (7.25 
mmol,0.174 g) dissolved in THF (20.6 mL) at 0°C under nitrogen.  After 3 h, 
MOMCl (0.5 mL) was added at 22° C overnight. Purification via flash column 
chromatography on silica gel (4% methanol in dichloromethane) resulted in  
the desired product (10) (1.098 g, 76.5% yield) (Scheme 2.3.7). 1H NMR 
(500 MHz, Chloroform-d, 294 K):  δ 8.35 (1 H, s), 7.15 (1 H, d, J 1.7), 7.14 
(1 H, d, J 1.2), 6.74 – 6.70 (1 H, m), 5.26 (1 H, s), 5.11 (1 H, s), 3.42 (3 H, 
s), 2.11 (3 H, s). 
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protected 2-chloro-3-formylquinolines(11).    
       Dry DMF (1.14 mL) and POCl3 (3.93 mL) were stirred at 0
° C under 
nitrogen. acetanilide (10) (6.034 mmol, 1.178 g) was added to the solution 
and the reaction mixture was stirred at room temperature for 10 min.  Then 
the mixture was heated at 75° C for 4 h.  The progress of the reaction was 
monitored by TLC. The liquid product was added to ice water and then 
sodium bicarbonate was added producing an orange precipitate that was 
collected by filtration and washed with water. Orange fluorescent powder 
was obtained. Purification was performed via flash column chromatography 
on silica gel (6% methanol in dichloromethane) but the 1H NMR (500 MHz, 
CDCl3) (Scheme 2.3.8) measurements showed the target product (11) was 





       Acetanilide (13) (24 mmol, 3.24 g) was added to a stirred solution of 
POCl3 (16 mL) in dry dimethylformamide, DMF,   (4.6 mL) at 0°C under 
nitrogen. After 10 min stirring at room temperature the mixture was heated 
at 75°C for 16h.  The progress of the reaction was monitored by TLC. Then 
the liquid product was added to ice water and was neutralized by adding 
potassium carbonate generating yellow precipitate (14) in (2.94 g, 64% 






   
2-amino -pyrimido[4,5-b]quinoline-one ring tC C(16).  
      To a stirred solution of guanidine HCl (0.96mmol, 0.09 g) in DMF (2 mL) 
over molecular sieves sodium hydride 60% in oil (0.64 mmol, 0.026 g) was 
added.  After 60 min 2-chloro-3-formylquinoline (0.16 mmol, 0.03 g) (14) 
was added and the mixture was heated at 80° C for 1 h. The precipitate 
produced was filtered and washed with 1:1 CH3OH: CH2Cl2. The purification 
via flash column chromatography on silica gel (20% methanol in 
dichloromethane) afforded the desired product 2-amino-tCC (16) (<10 % 
yield) (Scheme 2.3.10).   
2.4 Conclusion: 
         Since there are published papers that show how easy the synthesis of 
tCC fluorescent nucleotide is with the pyrimido[4,5-b]quinoline-2(1H)-one 
ring system,1  we spent a long time attempting to prepare tCC derivatives. 
We exactly followed some published procedures; however, using urea in 
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heated acetic acid for the cyclization reaction of 2-chloro-3-formylquinoline 
failed even under super dry conditions as the hydrolysis of 2-chloro-3-
formylquinoline takes place instead of the cyclization. Fortunately, using 
guanidine HCl in the last reaction for the cyclization worked as the 
nucleophile is stronger than urea because of the unshared pair of electrons 
on the nitrogen atom which gives more of a chance for the cyclization to  
occur instead of hydrolysis.  We have successfully synthesized 2-amino 
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        In this part of our procedure, we have designed two new fluorescent 
nucleosides analogues tC8OMe, tC7OMe (Figure 3.1.1); in addition we 
evaluated some of their photophysical properties as compared to 
Matteucci’s phenothiazine (tC).2 Moreover, we were looking for an improved 
synthetic route to prepare the non fluorescent nucleobase tCnitro which is 
considered to be an important molecule that uses as acceptor in FRET 
process.4,8 
        As stated previously (in chapter 1), this project aimed  to obtain a set of 
fluorescent nucleoside analogues that closely resemble cytosine by 
extending the aromatic surface (extended conjugation) to enhance the 




nucleoside analogues and evaluating their photophysical properties, this 
project aimed  to understand the effects of donor substituent on the 
photophysical properties of tC.      
       We are interested in synthesizing new fluorescent nucleoside tC 
derivatives because of the unique properties of the tC family. For example, 
the size and structure of tC analogues enable them to be incorporated site-
specifically into nucleic acids with minimal disturbance of the native 
structure.  Furthermore, tC analogues have shown their emission quantum 
and yield to be insensitive to changes in close bases after being 
incorporated into oligonucleotides. 2 Consequently, tC is significantly more 
useful for distance determinations than the other available fluorescent base 
analogues which have sensitive emission and quantum yields.5  However, 
tricyclic cytosine tC analogues have exhibited relatively low quantum yields 
around 0.2 for the tC analogue 5,8   and around 0.14 – 0.41 for tCO. 9 As a 
result, we were looking to improve the quantum yield by introducing tC 
derivatives which have a heteroatom -containing substituent such as a 




These substituents allow for extended conjugation of unshared pairs of 
electrons leading to high fluorescence quantum yields, and red-shifts in 




































        In order to provide novel structures that result in excellent 
photophysical properties for use as probes, we have designed modified 
novel nucleosides that are similar to the core structure of Matteucci´s 
phenothiazine (tC)2 nucleoside with substituted electron donor group,OCH3, 
which allows for extended conjugation of unshared pairs of electrons, at 
different positions  7C and 8C.  These different substitution positions offer 
important distinctions between the design of the tC, tC8OMe, and tC7OMe. The 
tC nucleoside without any addition functional groups was easy to 
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synthesize. In contrast, the synthetic strategy for the tC7OMe nucleoside that 
has a functional group OCH3, substitution para to the amine group 
synthetically less challenging and higher yielding than synthesis of tC8OMe  
which has the OCH3 group substitution meta to the amine group.  However, 
the fluorescence emission wavelength of tC8OMe shifted farther than the 
fluorescence emission wavelength of both tC and tC7OMe. 
             
 
3.2 General Synthetic Elaborations: 
      In general, the synthesis of fluorescent nucleobase analogues of the 
tricyclic cytosine (tC) family was convergent and was carried out in four 
main steps (scheme 3.2.1) (a) coupling,  (b) ring-closure, (c) glycosylation, 
and (d) hydrolysis, which will be clearly explained for each synthesis. 
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Scheme 3.2: Synthetic Elaboration of Fluorescent nucleoside analogues tC














































3.2.1 Synthesis of tC nucleoside 
 
 





       The fluorescent tC nucleoside, Matteucci´s phenothiazine, (Figure 
3.2.1) was synthesized in four steps (Scheme 3.2.1). The intermediate (3) 
and tC base (4) were synthesized using the same pathway that has been 
used in an article which  was published by Wilhelmsson and coworkers.5 
Beginning with the combination  of 5-bromouracil (2) with 2-aminothiophenol 
(1) heated in ethylene glycol in the presence of Na2CO3 for 1 h generated 
62%  yield (3).  Followed by the ring-closure step that was started by 
heating the product (3) in a solution of EtOH and HCl for 22 h produced tC 
base (4) in 73 % yield.  For the glycosylation, using sodium hydride (60% in 
mineral oil), which is a strong base, deprotonated O-H giving an alkoxide 
anion (R-O- Na+) salt, which has limited solubility in DMF.  In this case, the 
glycosylation reaction has the chance to occur at the anion oxygen as well 
as at the nitrogen in position 2, the yield of 3-(2-Deoxy-b-D-ribofuranosyl)-
1,3-diaza-2-oxophenothiazine was poor ~ 10–15%.5  We were able to 
increase  the glycosylation yield to 40% for a mixture of β and α anomeric 
2´-deoxy-3´,5´-di-O-p-toluoyl-phenothiazine (5) by using the same pathway 
which was published in an article by Leconte.6 Using the 
Bis(trimethylsilyl)acetamide we were able to protect the oxygen on the tC 
base (silylation of alcohol)  thus, the glycosylation reaction was directed 
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solely toward N-2 and the coupling was achieved in 40% yield.  The 
separation of individual β and α anomers is poor at this step, thus the 
anomeric mixture was carried through to the next step.  Toluoyl deprotection 
of the toluoylated phenothiazine (5) was achieved by using sodium 
methoxide in methanol for a combined yield of 0.0685 g, 43 %.  The free 
nucleosides were isolated separately β (6) and α (7) and identified 
depending on the elution profile from automated chromatography using an 












3.2.2  Synthesis of tC 8OMe nucleoside  
 
 
                     
 
 
       Synthesis of the tC8OMe nucleoside (Figure 3.2.2) was carried out in six 
steps (Scheme 3.2.2). In order to prepare the starting material 2-amino-4-
methoxythiophenol (10), the reaction was started with heating 5-methoxy-2-
methylbenzothiazole ethylene glycol and NaOH under nitrogen gas. 
Unfortunately, the resulting mixture contained more disulfide (9) than the 
target product 2-amino-4-methoxythiophenol (10). However, purification and 
isolation of the disulfide (9) produced just ~ 5% yield pure material. So we 
changed the procedure in order to improve the yield of the disulfide (9) by 
adding H2O2. 1-(4-methoxy-2-aminothiophenol)-4-methoxy-2-
aminothiophenol disulfide, (9) was successfully reduced to generate 2-
amino-4-methoxythiophenol (10). Reduction was done by treating it with 
dithiothreitol, DTT, or triphenylphosphine, PPh3. Using triphenylphosphine 
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produced triphenylphosphine oxide which is not easy to isolate from the 
target product, whereas using DTT enabled reduction of the disulfide bond 
and easy access to the intermediate 2-amino-4-methoxy-thiophenol (10). It 
may be useful to reduce the disulfide bond with PEt3 which was useful in 
reducing the disulfide bone in tC7OMe preparation (see below), but we did not 
try using PEt3 with this molecule. By adding 5-Bromouracil and Na2CO3  into 
the previous mixture and heating at 120° C, coupling was achieved, yielding 
product (11) in 33% yield.  The attempted synthesis of tC8oMe base (12) 
using the same pathway that was used in an article published by 
Wilhelmsson and coworkers 7  which is, heating the product (11) in EtOH 
and HCl solution at 80° C for 44 h produced product (12) in low yield ~ 5%. 
Fortunately, we have improved the yield to 30 % by changing the solvent to 
butanol instead of ethanol , thus we were able to heat the reaction at 116°C 
for 20 h generating the tC8OMe base (12) in 30% yield. For the glycosylation 
and for hydrolysis of toluoyl groups,  we have used the same pathway that 
was previously used by Leconte.6  The tC8OMe base (12) was coupled to 
3´,5´-bis(toluoyl)-2-deoxyribosyl in the presence of Bis(trimethylsilyl)-
acetamide to protect the oxygen on the tC8OMe base (silylation of alcohol). 
Thus, the glycosylation reaction was directed only toward N-2 of compound 
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(12) producing a mixture of β and α anomers of  2´-deoxy-3´,5´-di-O-p-
toluoyl- 8-methoxy-phenothiazine (13) in 40% yield.  The separation of β 
and α  is poor at this step, thus the anomeric mixture was carried through to 
the next step. Toluoyl deprotection of the toluoylated 8-methoxy-
phenothiazine (13) was achieved by using sodium methoxide in methanol, 
and the free nucleoside were isolated separately β (14) and α (15), 
identified depending on the elution profile from automated chromatography 
using Isco gradient (CombiFlash® Rf ) (100:0 →60:40, CH2Cl2: MeOH) then 










































































































3.2.3   Synthesis of tC 7OMe Nucleoside 









Figure3.2.3: The fluorescent tC7OMe nucleoside  
 
        Synthesis of the tC7OMe nucleoside (Figure 3.2.3) was carried out in six 
steps (Scheme 3.2.3). In order to prepare the starting material 2-amino-5-
methoxythiophenol (18), synthesis was first attempted using the same 
Wilhelmsson procedure using NaOH in ethylene glycol and heating at 120 
°C, that had been used previously for preparing the  tC8OMe base, but this 
produced a polymeric material, which we did not characterize. As a result, 
we changed the procedure by heating 6-methoxy-2-methylbenzothiazole in 
hydrazine monohydrate followed by oxidation of the sulfide molecule by the 
addition of hydrogen peroxide after cooling the reaction down to room 
temperature. The disulfide (17) was successfully reduced to generate the 
intermediate 2-amino-5-methoxythiophenol (18) by treating it with either 
triethylphosphine in 1M tetrahydrofuran, PEt3, or triphenylphosphine. Using 
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triphenylphosphine produced triphenylphosphine oxide which is not easy to 
isolate from the target product, whereas using PEt3 we were able to reduce 
the disulfide bond easily and this gave access to the intermediate 2-amino-
5-methoxythiophenol (18). By adding 5-Bromouracil and Na2CO3  into the 
previous mixture and heating at 120°C, coupling was achieved, yielding 
product (19) in 35% yield. First attempts to synthesize the tC7OMe base (20) 
were made by using the same pathway that had been used previously for 
the tC8OMe base by addition of HCl immediately to the mixture of starting 
material and butanol at room temperature then heating the mixture at 
160°C. This procedure did not produce any reaction because the starting 
material had limited solubility.  As a result, we changed the pathway by 
stirring compound (19) in butanol at 100°C for 10 min; in order to more 
completely the dissolve product (19) then added HCl after cooling the 
mixture down to room temperature for 5 min. The coupling was achieved by 
heating the reaction mixture at 116 °C overnight, an orange precipitate was 
generated which became yellow after washing with water yielding 61%. 
tC7OMe base (20).  No further purification was necessary for the tC7OMe base 




        For  the glycosylation and for the hydrolysis of toluoyl groups, we have 
used the same pathway that previously was used by Leconte.6  The tC7OMe 
base (20) was coupled to 3´,5´-bis(toluoyl)-2-deoxyribosyl in the presence of 
Bis(trimethylsilyl)acetamide that was able to protect the oxygen on the 
tC7OMe base (silylation of alcohol) thus, the glycosylation reaction was 
directed only toward the N-2 of compound (20) producing mixture of β and α 
anomers of  2´-deoxy-3´,5´-di-O-p-toluoyl- 7-methoxy-phenothiazine (21) in 
47% yield. The separation of β and α anomers is poor at this step, thus the 
anomeric mixture was carried through to the next step. Toluoyl deprotection 
of the toluoylated 7-methoxy-phenothiazine (21) was achieved by using 
sodium methoxide in methanol, and the free nucleoside anomers were 
isolated separately β (22) and α (23) were identified depending the elution 
profile from automated chromatography using an Isco gradient 
(CombiFlash® Rf 100:0 → 60:40, CH2Cl2: MeOH) then confirmed via 1H 








3.2.4  Synthesis of tC nitro  Nucleobase 
 
 






Figure3.2.4: The tCnitro nucleobase  
 
       tCnitro  nucleobase (Figure 3.2.4)  which was reported by Börjesson in 
2009 as the first base analogue FRET acceptor 4  , was synthesized in four 
steps are shown in Scheme (3.2.4). Unfortunately,  using the same pathway 
that has been used in an article that was published by Börjesson4  for the 
synthesis of this compound (27) generated a poor yield of around 12 %. 
This was the result of most of product oxidizing the starting material and 
thus producing a disulfide bond between two 5-nitro-2-aminothiophenol 
molecules.  In order to improve the yield, a disulfied bond between two 5-
nitro-2-aminothiophenol molecules was used as the starting material for the 
synthesis yielding product (27).  The ring of 6-Nitrobenzothiazole (24) was 
opened by the addition of hydrazine monohydrate in ethanol and  heating at 
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100 °C for 18h then the reaction was exposed to oxygen  in the fume hood 
to oxidize the sulfur which generated a disulfide bond between two 5-nitro-
2-aminothiophenol molecules, 1-(5-nitro-2-aminothiophenol)-5-nitro-2-
aminothiophenol (25). Reducing the disulfide bond was accomplished 
immediately via either DTT, PPh3 ,or Et3P.  Using triphenylphosphine 
produced triphenylphosphine oxide which is not easy to isolate from the 
target product, whereas using DTT or PEt3 we were able to reduce the 
disulfide bond easily and this gave access to  the intermediate 5-nitro-2-
aminothiophenol (26).  By adding 5-Bromouracil and Na2CO3  into the 
previous mixture and heating at 120° C for 17 h coupling was achieved 
yielding product (27).  The synthesis of the base tCnitro (28)  was the most 
challenging that we faced in the course of this lab work. The synthesis using 
the same pathway that has been used in an article that was published by 
Börjesson4 did not show any reaction even after heating the mixture at 116° 
C for two days. Also, there was no progress of the reaction after heating the 
mixture at 127° C for ~ 48h. Fortunately, the synthesis of the base tCnitro (28) 
was achieved by using the same pathway that has been used previously for 
synthesizing the tC8OMe base but by heating product (27) in butanol at a 
higher temperature (170° C) for 3 days producing a crude mixture containing 
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the target product (28) as was confirmed via mass spectral analysis. We did 
not try to purify the product yet, but someone from the group will do so in 








3.6 Photophysical properties of the fluorescent 
nucleosides 
 
       To understand the effects of the donor substituent group and their 
positions on the photophysical properties of the tC derivatives, and also to 
explore whether the features of the fluorescent nucleosides tC derivatives 
make them ideal for utilization as probes, and for further use in FRET 
experiments, the photophysical properties of the fluorescent nucleosides tC 
derivatives have been investigated.  
3.6.1   The Absorption of tC, tC8OMe, tC7OMe: 
 
        Figure 3.6.1shows the normalized absorption spectra of the tC,  tC8OMe, 
and tC7OMe  nucleoside analogues as a dilute solution in Ethanol (~10µM). 
The tC8OMe analogue, shows a red shift absorption that peaks at 
approximately 377 nm whereas the tC7OMe spectrum appears as two peaks 
one at approximately 325 nm and an unclear peak at approximately 374 
nm, and the tC shows absorption that peaks at approximately 371 nm. On 
the other hand, the spectra of the absorption measurements of the tC 
nucleoside derivatives as dilute (~10 µM) solutions in water shows that the 
tC8OMe is the most red shifted absorption that peaks at 381 nm while the 
tC7OMe spectrum shows two peaks at approximately 327 nm and 376 nm, 
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and the tC shows absorption maximum at 377 nm. Consequently, the 
absorption of each nucleoside, tC, tC8OMe, and tC7OMe, is minimally sensitive 
to changes in solvent polarity as is clear in table 3.6.1. 
 
Figure 3.6.1:   The normalized absorption spectra of tC,  tC8OMe, and tC7OMe in EtOH and in 
H2O  
 
3.6.2 The Fluorescence Emission and Excitation of t C 
derivatives:  
 
      Figure 3.6.2a shows the normalized excitation and emission spectra of 
the tC,  tC8OMe, and tC7OMe nucleosides in ethanol. Upon excitation at 381nm 
of a dilute solution (10 µM) in ethanol, the nucleoside tC8OMe displays an 
emission that peaks at ~518 nm. On the other hand, the nucleosides tC7OMe 
and tC exhibit shorter emission wavelengths that peak at ~498 nm, and 





       The emission measurements were made with different concentrations 
(between 1µM to 5 µM) in EtOH for each nucleoside and the emission 
wavelengths were: tC 485.07-488.05 nm, tC8OMe 512.98 - 509.85 nm, and 
tC7OMe 494.09-499.09 nm 
      Figure 3.6.2b shows the normalized excitation and emission spectra of 
the tC,  tC8OMe, and tC7OMe nucleosides in ethanol. A dilute solution (10 µM) 
in water, the nucleoside tC8OMe displays an emission that peaks at ~536 nm. 
On the other hand, the nucleosides tC7OMe and tC exhibit shorter emission 
wavelengths that peak at ~517 nm, and ~501 nm respectively. 
 
 
Figure 3.6.2a: The excitation and emission spectra of tC,  tC8OMe, tC7OMe nucleosides in 





Figure 3.6.2b: The excitation and emission spectra of tC,  tC8OMe, tC7OMe nucleosides in 
H2O (conc. 10µM) 
 
 
Nucleoside Solvent λem nm λabs nm 
tC H2O 501.9  377 
tC EtOH 482.9 371 
tC7OMe H2O 517.0 376 & ~ 327 
tC7OMe EtOH 497.8 374 & 325 
tC8OMe H2O 536.9  381 
tC8OMe EtOH 517.9 377 
 
Table 3.6.1:  Absorption and Fluorescence emission maxima of tC derivatives                                                                           
in H2O and in EtOH 
 
3.6.3 Quantum yields 
       Quantum yields were determined using anthracene (ΦF=0.27 in 
ethanol) as a standard 7 for comparison to the nucleosides tC, tC8OMe, and 
tC7OMe. The quantum yields of all nucleosides (tC, tC8OMe, and tC7OMe) were 




φX = φS[GradX /GradS] X /   S                                                                      Equation 
1 
Where ΦX is the unknown quantum yield of tC the nucleoside analogue. ΦS 
is the quantum yield of anthracene. Grad is the slope from the plot of the 
integrated fluorescence intensity versus the absorbance at the excitation 
wavelength. X= S is the refractive index of the solvent (1.36 for ethanol ). 
The nucleosides tC8OMe, tC7OMe and tC exhibits fluorescence quantum yields 
in etanol of φF = 0.43, 0.86, 0.17 respectively.    
 
 
Figure 3.6.3a:  Plot of integrated emission versus absorption to 







Figure 3.6.3b:  Plot of integrated emission versus absorption to 





Figure 3.6.3c:  Plot of integrated emission versus absorption to 
determine the quantum yield of tC7OMe 
 
3.6.4 Molar Extinction Coefficients: 
    The molar extinction coefficients of all nucleosides (tC, tC8OMe, and 
tC7OMe) were measured using a Varian Cary 100 Bio Spectrophotometer, 
and determined using the Beer’s Law equation: 
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Aλ = εcL = εc when L = 1 cm                                          Equation 2 
Where, ε: molar absorptivity, A: absorbance, and c: molar concentration. 
The molar absorptivities for tC, tC8OMe, and tC7OMe were calculated via the 
slop of a plot of absorption versus concentration (Figure 3.7.4) to be 8300 






Figure 3.6.4:  Plot of absorption versus concentration for tC analogues 
From the molar absorptive we can calculate another quantification of the fluorescence 






Brightness = ε x φF                                                                Equation 3 
Nucleoside Solvent Quantum 












-1   
tC EtOH 0.17 8300 1411 
tC8OMe EtOH 0.43 5200 2080 
tC7OMe EtOH 0.86 5400 4644 
 
Table 3.6.2:  Fluorescence quantum yields, molar absorptivity, and brightness in EtOH   
 
                                                                                      
3.7 Experimental 
Synthesis of tC nucleoside analogue derivatives and  the 
nucleobase tC nitro 
 
General   
 
         Solvents and reagents were obtained from commercial suppliers and 
used without further purification. All moisture and oxygen sensitive reactions 
were carried out under nitrogen. Air and moisture sensitive solvents and 
solutions of reactions were transferred by syringe. Reactions were 
monitored by thin layer chromatography (TLC). NMR spectra were recorded 
on a Bruker Avance 500MHz spectrometer. UV-Vis absorption spectra were 
recorded on a Varian Cary 100 Bio Spectrophotometer, and fluorescence, 
excitation, and emission spectra were recorded on a Varian Cary Eclipse 
Fluorimeter. Mass spectra were measured at the Central Analytical 
Laboratory at the University of Colorado at Boulder. Unless otherwise 
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specified, purifications were performed using Teledyne Isco advanced 




























 2,4-Dihydroxy-5-(2-amino-phenylthio)pyrimidine(3).   
     2-aminothiophenol (1) (22.33 mmol, 2.8 g) was dissolved in ethylene 
glycol (10 mL) under nitrogen gas. 5-bromouracil (2) (16.6 mmol, 3.16 g) 
and Na2CO3 (16.6 mmol, 1.76g) were added to the solution.  The mixture 
was heated at 120° C for an hour then was allowed to cool to room 
temperature before adding water (30 mL) then the reaction was neutralized 
by dropwise addition of ~2 mL acetic acid pH indicator paper was used to 
check that the neutralization was complete and the pH of the mixture was 7. 
A yellow precipitate was collected via filtration and washed first with water 
and then ethanol until the precipitate had become colorless. The precipitate 
was finally washed with a small volume of ether to facilitate drying.  The 
precipitate was dissolved in warm 0.02 M Sodium hydroxide (33 mL) 
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warmed to ~50° C then the mixture was neutralized to  pH ~7 with acetic 
acid. The mixture was filtered and the white precipitate was washed first 
with water, then with ethanol and finally with ether. A white precipitate 
formed which was product (3) (2.2 g) in 62% yield. 1H NMR (500 MHz, 
DMSO-d6, 294 K):  δ 11.36 (1 H, s), 11.16 (1 H, s), 7.53 (1 H, d, J 1.6), 7.31 
(1 H, dt, J 7.7, 1.7), 7.08 – 7.03 (1 H, m), 6.70 (1 H, dt, J 8.2, 1.5), 6.50 (1 
H, tt, J 7.4, 1.6), 5.52 (2 H, s). 
           
 
1,3-diaza-2-oxophenothiazine (tC base)  (4). 
      2,4-Dihydroxy-5-(2-amino -phenylthio)pyrimidine (3) (3.625 mmol, 0.853 
g)  was stirred in ethanol (17.3 mL)  then HCl (1.73 mL) was added 
dropwise. The reaction mixture was stirred at 80 °C for  22 h. The reaction 
mixture was cooled to room temperature and filtered. The precipitate was 
added to a stirred, warm (50 °C) aqueous 5% ammonia solution. After 5 min 
the solution was filtered. This washing procedure was repeated twice. The 
yellow product was finally washed with water and left to dry overnight to 
80 
 
yield compound (4) in 0.575 g, 73% yield. 1H-NMR (500 MHz, DMSO-d6, 
294 K):  δ 10.24 (1 H, s), 7.42 (1 H, s), 7.10 – 7.00 (2 H, m), 6.92 (2 H, d, J 
8.0). 
           
                   
 2´-deoxy-3´,5´-di-O-p-toluoyl-phenothiazine(5). 
      1,3-diaza-2-oxophenothiazine (tC base)  (4) (0.299 mmol, 0.065 g)  was 
stirred in anhydrous acetonitrile (1.4 mL, 99%) for 10 min at room 
temperature under nitrogen. Bis(trimethylsilyl)acetamide (0.102 mL)  was 
added to the solution. After 40 min of stirring at room temperature 3´,5´-
bis(toluoyl)-2-deoxyribosyl chloride (0.383 mmol, 0.149 g)  was added at 0 
ºC followed by (6 µl ) SnCl4 dropwise.   After 4 h, 2´-deoxy-3´,5´-di-O-p-
toluoyl-phenothiazine (5) was generated. The progress of the reaction was 
monitored by TLC. The mixture was diluted with ethyl acetate (8 mL) and 
the resulting solution was washed with saturated NaHCO3 (3x20 mL) and 
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brine (1x20 mL). The organic layer was dried over anhydrous Na2SO4, and 
concentrated using a rotary evaporator. Purification via flash column 
chromatography on silica gel (CH2Cl2: MeOH, 100:0 → 0:100) afforded the 
desired product (5) in a mixture of α and β anomers, 0.068g, 40 % yield. 
1H NMR (500 MHz, Chloroform-d, 294 K):  δ 7.92 – 7.88 (3 H, m), 7.76 – 
7.70 (1 H, m), 7.43 (1 H, d, J 12.4), 7.07 (1 H, dd, J 8.0, 7.1, 1.8), 7.00 – 
6.97 (3 H, m), 6.93 – 6.89 (1 H, m), 6.86 (1 H, dd, J 8.0, 1.2), 6.36 (1 H, dd, 
J 8.2, 5.6), 6.30 (1 H, dd, J 6.7, 1.1), 5.64 – 5.57 (2 H, m), 5.53 (1 H, dd, J 
8.1, 6.2, 1.9), 4.88 (1 H, t, J 4.3), 4.78 (1 H, dd, J 12.2, 3.0), 4.66 (1 H, dd, J 
12.3, 3.3), 4.59 (1 H, q, J 2.9), 4.55 – 4.51 (2 H, m), 4.45 – 4.40 (1 H, m), 








         2´-deoxy-3´,5´-di-O-p-toluoyl-phenothiazine (5) (0.478 mmol, 0.159 g)  
was  dissolved in (5 mL) absolute methanol at room temperature. NaOMe 
(30% wt. 5.4 M, 99% in methanol) (0.1mL) was added dropwise to the 
solution.  The progress of the reaction was monitored by TLC.  After 30 min 
the reaction was complete, and drops of acetic acid were added to quench 
the reaction. The solvent was removed by evaporation using a rotary 
evaporator. Purification via flash column chromatography on silica gel 
(CH2Cl2: MeOH, 100:0 → 45:55) afforded free isolated nucleoside anomers 
β (6) and α (7)  that were identified depending on the elution profile from 
automated chromatography using an Isco gradient (CombiFlash® Rf ) and 
confirmed via 1H NMR 500.  The combined yield is 0.0685 g, 43 %.    
β-anomer  
        1H NMR (500 MHz, Methanol-d4, 294 K):  δ H (500 MHz, Methanol-d4) 
7.93 (1 H, s), 7.91 – 7.86 (1 H, m), 7.26 (1 H, d, J 8.0), 7.07 (1 H, td, J 7.7, 
1.5), 6.99 (1 H, dd, J 7.9, 1.5), 6.96 – 6.92 (1 H, m), 6.85 (1 H, dd, J 8.1, 
1.1), 6.18 (1 H, t, J 6.3), 4.36 (1 H, dt, J 6.4, 4.0), 3.93 (1 H, q, J 3.5), 3.81 




       1H (500 MHz, Methanol-d4, 294 K)   δ 7.69 (1 H, s), 7.10 – 7.03 (1 H, 
m), 7.00 (1 H, dd, J 7.8, 1.5), 6.94 (1 H, td, J 7.5, 1.3), 6.86 (1 H, d, J 1.3), 
6.84 (1 H, d, J 1.3), 6.09 (1 H, dd, J 7.2, 2.1), 4.35 – 4.30 (3 H, m), 3.63 – 
3.55 (3 H, m), 2.70 – 2.62 (1 H, m), 2.08 (1 H, dt, J 14.6, 2.1). 
 
 
1-(4-methoxy-2-aminothiophenol)-4-methoxy-2-amino-t hiophenol(9).  
      5-methoxy-2-methyl benzothiazole (8) (5.57mmol, 1g) was dissolved in 
ethylene glycol (6 mL) under nitrogen gas. NaOH (6 mL, 10 M) was added 
and the mixture was heated at 125°C overnight. Unfortunately, the product 
mixture contained more 1-(4-methoxy-2-aminothiophenol)-4-methoxy-2-
aminothiophenol without nitrogen gas followed by the addition of H2O2 after 
cooling of the reaction to room temperature to increase the chance of 
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oxidizing the sulfur bond. The yellow product 1-(4-methoxy-2-
aminothiophenol)-4-methoxy-2-aminothiophenol,  disulfide (9) was isolated 
via flash column chromatography on silica gel (CH2Cl2: MeOH, 100:0 → 
95:5) in 0.859 g, 68% yield, which is more than the target product 2-amino-
4-methoxythiophenol (10) 1H NMR (500 MHz, DMSO-d6, 294 K):  δ 6.88 (1 
H, d, J 8.5), 6.32 (1 H, d, J 2.7), 6.05 (1 H, dd, J 8.5, 2.7), 5.45 (2 H, s), 3.68 
(3 H, s).,  disulfide (9) than 4-methoxy-2-aminothiophenol (10) . As a result, 







2,4-Dihydroxy-5-(2-amino-4-methoxy-phenylthio)pyrim idine (11).   
      1-(4-methoxy-2-aminothiophenol)-4-methoxy-2-aminothiophenol(9) 
(1.02 mmol, 0.316 g) was dissolved in diglyme(4 mL), and was reduced to 
2-amino-4-methoxythiophenol (10) by heating with dithiothreitol, DTT, (1.02 
mmol, 0.158 g)  under nitrogen at 80°C.  After 30 min 5-Bromouracil (2.1 
mmol, 0.416 g) and Na2CO3 (2.04 mmol, 0.216 g) were added and the 
mixture was heated at 120°C 2 h. The solvent was removed by evaporation 
using rotary evaporator.  Purification via flash column chromatography on 
silica gel (5% methanol in dichloromethane) afforded the desired product 
(11) in 0.18 g, 33% yield.   1H NMR (500 MHz, DMSO-d6, 294 K):  δ 11.33 
(2 H, s), 7.27 (1 H, d, J 8.5), 6.27 (1 H, d, J 2.7), 6.12 (1 H, d, J 2.7), 6.11 (1 





8-methoxy-1,3-diaza-2- oxophenothiazine  nucleoside ( tC8OMe base)  
(12). 
 
       2,4-Dihydroxy-5-(2-amino-4-methoxy-phenylthio)pyrimidine (11) (0.49 
mmol, 0.13 g)  was dissolved in butanol (1 mL). While the mixture was 
stirring, HCl (0.5 mL, 37%) was added dropwise. The reaction mixture was 
heated at 116° C.  After 22 h the mixture was cooled to room temperature 
and the solvent was removed by evaporation via rotary evaporation. 
Purification via flash column chromatography on silica gel (8% methanol in 
dichloromethane) afforded the desired product (12) in 0.036 g, 30% yield. 
1H-NMR (500 MHz, DMSO-d6, 294 K):  δ 11.04 (1 H, s), 10.16 (1 H, s), 7.42 
(1 H, s), 6.96 (1 H, d, J 8.5), 6.58 (1 H, s), 6.53 (1 H, dd, J 8.6, 2.7), 3.68 
(3H, s). (ESI-TOF) m/z: calcd. for C11H9N3O2S [M+H] 248.29 found 248.0. 
ESI-TOF) m/z: calcd. for C11H9N3O2S [M+Na] 270.26 found 270.0.  




2´-deoxy-3´,5´-bis-O-p-toluoyl-8-methoxy-phenothiazi ne (13).  
        8-methoxy-1,3-diaza-2- oxophenothiazine  nucleoside (tC8OMe base)  
(12) (0.877 mmol, 0.2 g) was stirred  in anhydrous acetonirile 99% (2.12 
mL)  at room temperature under nitrogen for 10min. Bis(trimethylsilyl) 
acetamide (0.3 mL)  was added to the solution.  After 40 min, the reaction 
was cooled to 0° C. 3´,5´-bis(toluoyl)-2-deoxyribosyl chloride (1.13 mmol, 
0.44 g) was added, and followed by dropwise addtion of  SnCl4 (6 µl ). The 
progress of the reaction was monitored by TLC.  The reaction was 
completed after 4 h. The mixture was dissolved in ethyl acetate (3 mL), and 
the resulting solution was washed with saturated NaHCO3 (3x20 mL) and 
brine (1x20 mL). The organic layer was dried over anhydrous Na2SO4, and 
concentrated using a rotary evaporator. Purification via flash column 
chromatography on silica gel (100:0 →60:40, CH2Cl2: MeOH) afforded the 
desired product (13) as a  mixture of β and α anomers ~ 1:1, 0.21 g, 40% 
yield.    1H NMR (500 MHz, Chloroform-d, 294 K):  δ 7.94 (2 H, d, J 1.5), 
7.93 (2 H, d, J 1.4), 7.90 (1 H, d, J 1.6), 7.88 (1 H, d, J 1.7), 7.73 (1 H, d, J 
1.8), 7.72 (1 H, d, J 1.8), 7.46 (1 H, s), 7.44 (1 H, s), 7.21 (1 H, s), 7.20 (1 H, 
s), 7.02 (1 H, s), 7.00 (1 H, s), 6.88 (1 H, d, J 8.6), 6.81 (1 H, d, J 8.5), 6.71 
(1 H, d, J 2.6), 6.59 (2 H, t, J 2.7), 6.57 (1 H, d, J 2.5), 6.55 (1 H, dd, J 8.5, 
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2.5), 6.33 (1 H, dd, J 8.0, 5.5), 6.28 (1 H, d, J 6.5), 5.62 (1 H, d, J 5.8), 5.59 
(1 H, d, J 6.4), 4.89 (1 H, t, J 4.3), 4.78 (1 H, dd, J 12.3, 2.9), 4.66 (1 H, dd, 
J 12.2, 3.3), 4.60 (1 H, q, J 2.8), 4.54 – 4.51 (2 H, m), 3.79 (3 H, s). 
 
  3-(2-Deoxy-b-D-ribofuranosyl)-8-methoxy-1,3-diaza -oxo-phenothiazine 
(14) & (15).  
      2´-deoxy-3´,5´-bis-O-p-toluoyl-8-methoxy-phenothiazine (13) (0.35 
mmol, 0.209 g)  was dissolved in absolute methanol (5 mL)  at room 
temperature. NaOMe (30% wt. 5.4 M, 99% in methanol) (0.1 mL) was 
added dropwise to the solution.  After 30 min the reaction was complete, 
and drops of acetic acid were added to quench. The solvent was removed 
by evaporation using a rotary evaporator. Purification via flash column 
chromatography on silica gel (CH2Cl2: MeOH, 100:0 →  55:45) afforded free 
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isolated nucleoside anomers (14) & (15) β and α respectively that were 
identified depending on the elution profile from automated chromatography 
using an Isco gradient (CombiFlash® Rf ) and confirmed via 1H NMR 500. 
The combined yield is 0.042 g, 34 %.   
β anomer 
1H NMR (500 MHz, Methanol-d4, 294 K):  δ 7.93 (1 H, s), 6.91 (1 H, d, J 
8.6), 6.58 (1 H, d, J 2.6), 6.56 (1 H, d, J 2.6), 6.51 (1 H, d, J 2.5), 6.19 (1 H, 
t, J 6.4), 4.93 (1 H, s), 4.85 (1 H, s), 4.61 (1 H, s), 4.37 – 4.35 (1 H, m), 3.93 
(1 H, p, J 3.5), 3.82 (1 H, dd, J 12.1, 3.1), 3.75 (3 H, s), 2.36 (2 H, ddd, J 
13.6, 6.1, 4.0), 2.17 – 2.15 (1 H, m), 2.15 – 2.11 (1 H, m). 
α anomer 
1H NMR (500 MHz, Methanol-d4, 294 K):  δ 7.69 (1 H, s), 6.93 – 6.89 (1 H, 
m), 6.57 (1 H, dd, J 8.6, 2.6), 6.51 (1 H, d, J 2.6), 6.09 (1 H, dd, J 7.2, 2.1), 
4.81 (1 H, s), 4.61 (3 H, s), 4.34 (2 H, dd, J 4.7, 3.4), 3.80 (1 H, s), 3.75 (3 






1-(5-methoxy-2-aminothiophenol)-5-methoxy-2-amino-t hiophenol (17).    
       Hydrazine monohydrate (10 mL) was added to 6-methoxy-2-methyl-
benzothiazole (16) (5.58 mmol, 1g).  The mixture was heated at 100° C for 
22 h. Hydrogen peroxide was added dropwise and the mixture was left to 
evaporate in the hood two days. The crude product was dissolved in 
methanol and precipitated by the addition of water. The afforded yellow 
precipitate was collected via filtration and washed with water affording the  
desired product (17) in 0.504 g, 60% yield. 1H NMR (500 MHz, DMSO-d6, 
294 K):  δ 6.77 (1 H, dd, J 8.7, 2.9), 6.70 (1 H, d, J 8.8), 6.59 (1 H, d, J 2.9), 




2,4-Dihydroxy-5-(2-amino-5-methoxy-phenylthio)pyrim idine (19).    
       1-(5-methoxy-2-aminothiophenol)-5-methoxy-2-aminothiophenol (17) 
(1.67 mmol, 0.515g) was dissolved in diglyme (10 mL). Triethylphosphine in 
1 M tetrahydrofuran (1.669 mL) and water (0.03 mL) were added to reduce 
the disulfide bond and afforded 2-amino-5-methoxythiophenol (18) at room 
temperature.  After 30 min, 5-Bromouracil (3.34 mmol, 0.637g) and Na2CO3 
(3.34 mmol, 0.353 g) were added. The mixture was heated at 120°C for 1h. 
The solvent was removed by evaporation using a rotary evaporator. 
Purification via flash column chromatography on silica gel (CH2Cl2: MeOH, 
100:0 → 20:80) afforded the desired product (19) in 0.307 g, 35% yield.1H-
NMR (500 MHz, DMSO-d6, 294 K):  δ 11.28 (2 H, d, J 74.4), 7.59 (1 H, s), 
6.89 (1 H, d, J 2.9), 6.72 (1 H, dd, J 8.8, 2.9), 6.65 (1 H, d, J 8.7), 5.05 (2 H, 




          
 
 7-methoxy-1,3-diaza-2- oxophenothiazine  nucleoside (tC7OMe base)  
(20).  
         2,4-Dihydroxy-5-(2-amino-5-methoxy-phenylthio)pyrimidine (19) (0.58 
mmol, 0.154 g) was stirred in butanol (10 mL) at 100°C for 10 min. The 
mixture was cooled to room temperature, followed by dropwise addition of 
HCl (1 mL, 37%). The reaction mixture was heated overnight at 116°C, an 
orange precipitate was generated which became yellow after washing with 
water yielding 0.087g, 61%. tC7OMe base (20).  No further purification was 
necessary for the tC7OMe base (20).  1H-NMR (500 MHz, DMSO-d6, 294 K):  
δ 10.90 (1 H, s), 10.11 (1 H, s), 7.38 (1 H, s), 6.84 (1 H, d, J 8.6), 6.65 (2 H, 




found 248.1. (ESI-TOF) m/z: calcd. for C11H9N3O2S [+Li
+] 254.21 found 
254.1. (ESI-TOF) m/z: calcd. for C11H9N3O2S [Na
+] 270.26 found 270.0. 
 
 
 2´-deoxy-3´,5´-bis-O-p-toluoyl-7-methoxy-phenothia zine(21).  
        7-methoxy-1,3-diaza-2- oxophenothiazine  nucleoside (tC7OMe base)  
(20) (0.39 mmol, 0.096 g) was dissolved in anhydrous acetonitrile 99% (1 
mL) at room temperature under nitrogen for 10 min.  
Bis(trimethylsilyl)acetamide (0.133 mL) was added to the solution. After 40 
min stirring at room temperature, 3´,5´-bis(toluoyl)-2-deoxyribosyl chloride 
(0.504 mmol, 0.194 g) was added at 0º C followed by  dropwise addition of 
SnCl4 (8.34 µl). The progress of the reaction was monitored by TLC. The 
reaction was completed after 4 h, the mixture was dissolved in ethyl 
acetate, and the resulting solution was washed with saturated NaHCO3 
94 
 
(3x20 mL) and brine (1x20 mL). The organic layer was dried over 
anhydrous Na2SO4, and concentrated by evaporation of the solvent by a 
rotary evaporator. Purification via flash column chromatography on silica gel 
(100:0 → 60:40, CH2Cl2: MeOH) afforded the desired product (21) in 
mixture of α and β anomers 0.1093 g, 47% yield. 1H-NMR (500 MHz, 
Chloroform-d, 294 K):  δ 8.03 (2 H, d, J 7.9), 7.96 – 7.92 (4 H, m), 7.91 – 
7.88 (2 H, m), 7.75 – 7.73 (1 H, m), 7.21 (2 H, d, J 8.1), 7.02 (1 H, d, J 7.9), 
6.87 (0 H, d, J 8.7), 6.79 (1 H, d, J 8.7), 6.67 (1 H, dd, J 8.7, 2.7), 6.61 (1 H, 
dd, J 8.7, 2.7), 6.53 (0 H, d, J 2.7), 6.46 (1 H, d, J 2.7), 6.35 (1 H, dd, J 8.2, 
5.5), 6.29 (1 H, d, J 6.4), 5.63 – 5.56 (2 H, m), 4.88 (1 H, t, J 4.2), 4.78 (1 H, 
dd, J 12.3, 3.0), 4.66 (1 H, dd, J 12.2, 3.3), 4.58 (1 H, q, J 2.8), 4.55 – 4.51 








phenothiazine (22) & (23)  
   
        NaOMe (30% wt. 5.4 M, 99% in methanol) (0.2 mL) was added 
dropwise to 2´-deoxy-3´,5´-bis-O-p-toluoyl-7-methoxy-phenothiazine (21) 
(0.0233 mmol, 0.014 g)  dissolved in methanol (3 mL) at room temperature. 
After 30 min the reaction was complete, and drops of acetic acid were 
added to quench the reaction then the solvent was removed by evaporation 
with a rotary evaporator. Purification via flash column chromatography on 
silica gel (CH2Cl3: MeOH, 100:0 → 60:40) afforded isolated free nucleoside 
anomers  β and α  that were identified depending on the elution profile from 
automated chromatography using an Isco gradient (CombiFlash® Rf ) in 
yield (~ 9.46 % β & 4.72 % α and mixture α >> β  yield 43.7%)  and 
confirmed via 1H NMR 500. In combined is yield 0.0057 g, 67 %. (ESI-TOF) 
m/z: calcd. for C32H29N3O7S [+H
+] 600.66 found 600.2. (ESI-TOF) m/z: 
calcd. for C32H29N3O7S [+Li
+] 606.59 found 606.2. (ESI-TOF) m/z: calcd. for 
C32H29N3O7 [+Na














































2,4-Dihydroxy-5-(2-amino-5-nitro-phenylthio)pyrimid ine (tC nitro ) (27).  
       6-Nitrobenzothiazole (24) (13.87 mmol, 2.5 g) was dissolved in ethanol 
(28 mL). After 5 min, hydrazine monohydrate (28 mL) was added to the 
solution.  The reaction mixture was heated at 100 °C for 18h. The 1-(5-nitro-
2-aminothiophenol)-5-nitro-2-aminothiophenol, nitro-disulfide, (25) was 
generated and collected via filtration then washed with water to afford the 
yellow product in around ~100% yield. 1H NMR (500 MHz, DMSO-d6, 294 
K):  δ 7.99 (1 H, dd, J 9.2, 2.7), 7.49 (1 H, d, J 2.7), 7.23 (2 H, s), 6.85 (1 H, 
d, J 9.2). 1-(5-nitro-2-aminothiophenol)-5-nitro-2-aminothiophenol, nitro- 
disulfide, (25) (0.65 mmol, 0.22 g) was dissolved in diglyme (8 mL).  
Dithiothreitol (1.08 mmol, 0.167g) and water (0.03 mL) were added to 
reduce the disulfide bond, and the reaction mixture was heated at 80°C to 
afford 5-nitro-2-aminothiophenol (26).  5-Bromouracil (1.3 mmol, 0.248 g) 
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and Na2CO3 (1.3 mmol, 0.137 g) were added. The mixture was heated at 
120°C for 17 h.  The mixture was left to evaporate in the hood two days. 
Purification via flash column chromatography on silica gel (5% methanol in 
dichloromethane) afforded the desired product (27) in 0.156 g, 71 % yield.  
1H-NMR (500 MHz, DMSO-d6, 294 K):  δ 8.24 (2 H, d, J 2.7), 8.06 (2 H, s), 
6.74 (1 H, s), 6.73 (1 H, s), 5.76 (2 H, s). (ESI-TOF) m/z: calcd. for 
C12H10N4O4S2 [+H
+] 281.27 found 281.0. (ESI-TOF) m/z: calcd. for 
C12H10N4O4S2 [+K
+] 319.36 found 319.0. (ESI-TOF) m/z: calcd. for 
C12H10N4O4S2 [+Na




                           
 
  
7-nitro-1,3-diaza-2- oxophenothiazine  nucleobase (tC nitro  base)  (28).  
       2,4-Dihydroxy-5-(2-amino-5-methoxy-phenylthio)pyrimidine (27) (0.082 
mmol, 0.23 g) was stirred in  butanol (1.15 mL) followed by dropwise 
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addition of  HCl (0.4 mL, 37%). The reaction mixture was heated 3 days at 
170°C.  The crude product was left to dry in the hood.  The NMR 
measurement shows the target product (28) was generated.  1H-NMR (500 
MHz, DMSO-d6, 294 K):  δ 7.40 (1 H, s), 7.39 (2 H, d, J 1.8), 7.37 (1 H, s), 
5.45 (1 H, d, J 1.6), 5.44 (1 H, d, J 1.8). (ESI-TOF) m/z: calcd. for 
C10H6N4O3S [+H
+] 263.25 found 263.0. (ESI-TOF) m/z: calcd. for 
C10H6N4O3S [M
+•] 262.24 found 262.0. (ESI-TOF) m/z: calcd. for 
C10H6N4O3S [+Li
+] 269.19 found 269.0. (ESI-TOF) m/z: calcd. for 
C10H6N4O3S Na [+Na
+] 285.23 found 285.0.             
              
3.8 Conclusion  
         We have successfully synthesized two new tC fluorescent nucleosides 
with methoxy substitutions, tC8OMe (Figure 3.2.2) , tC7OMe(Figure 3.2.3) ,  in 
addition to preparing tC (Figure 3.2.1) which has been reported previously 
by Matteucci and co-workers 2, and introduced a new synthetic route to 
tCnitro  that previously had been prepared in low yield by Börjesson et. al. 
2009.4  
      The fluorescence study on the tC derivatives suggested that the 
emission spectra in ethanol of tC8OMe, with a maximum at ~ 518 nm, has the 
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greatest red shift, approximately 35 nm as compared to tC with a maximum 
at ~ 483 nm.  The emission spectra of tC7OMe, with a maximum at ~ 498 nm 
is slightly red-shifted, approximately 15 nm as compared to tC. Likewise, the 
emission spectrum in water of tC8OMe, with a maximum at ~ 537 nm, has the 
greatest red shift, approximately 35 nm as compared to tC with a maximum 
at ~ 502 nm, while the emission spectrum of tC7OMe, with a maximum at ~ 
517 nm was slightly red-shifted, approximately 15 nm as compared to tC.  
       The absorption spectrum of tC8OMe is also red-shifted compared to the 
absorption spectrum of tC.  The absorbance maximum of tC8OMe is generally 
around 377 nm in ethanol, and 381 nm in water, which means that it is red-
shifted approximately 4 nm compared to the absorbance maximum of tC 
that is generally around 373 nm in ethanol, and 377 nm in water. Whereas 
the absorbance maximum of tC7OMe is generally around 374 in ethanol, and 
376 nm in water, which means that it is red-shifted in ethanol, but blue 
shifted in water approximately 1 nm compared to tC.    
     The quantum yields of both tC8OMe and tC7OMe, that were calculated via a 
plot of integrated emission versus absorption (Figure 3.7.3), were relatively 
high (0.38, and 0.8 respectively) compared to the tC quantum yield of 0.21.  
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These results demonstrated that the tC7OMe, which has the methoxy donor 
group para to the amino group, has the highest quantum yield and 
brightness. 
         To sum up, our results suggest that the different substitution positions 
create important distinctions between the nucleosides derivatives of tC. The 
unsubstituted tC nucleoside was easy to synthesize. In contrast, the 
synthetic strategy of the tC7OMe nucleoside that has the methoxy electron 
donor substituent group located at carbon 7 and para to the amino group is 
synthetically less challenging and higher yielding than the synthesis of 
tC8OMe which has the methoxy group substituent meta to the amine group. 
Moreover, the donor substituent and the position of the substituent have 
affected the photophysical properties of the fluorescent nucleoside 
derivatives of tC.  The fluorescence studies demonstrated that fluorescence 
emission and absorption wavelengths for tC7OMe and tC8OMe were red shifted 
compared to the unmodified tC. That means, the methoxy donor group 
which allows for extended conjugation of unshared pairs of electrons leads 
to an increase in the freedom of the -electrons and this is likely to raise the 
fluorescence.  Also, our fluorescence study established that there are 
effects of the different positions of the substituent donor group. The 
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fluorescence emission wavelength of tC8OMe, where methoxy is meta to the 
amino group, is red shifted longer than the fluorescence emission 
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